Peru is conducting simultaneous negotiations with 13 international laboratories in order to secure access to future supply of COVID-19 vaccines, as reported Andina.
Immunisation advisor at the Health Ministry (Minsa) Carlos Castillo noted that South American nation has signed non-binding agreements with 11 of the labs.
Sinopharm, Oxford/AstraZeneca, Moderna, Pfizer, Sinovac, Gamaleya, Novavax, Johnson & Johnson, Covaxx and Arcturus, plus the COVAX Facility coalition are still in the process of negotiation and are already conducting Phase III trials of their vaccines.
"Peru is open to all procurement possibilities, and we will move ahead with negotiations as pharmaceutical laboratories provide more updates on the progress made in developing their vaccines, mainly on their safety and effectiveness, as well as on the delivery schedule," Castillo said.
Peru has so far initiated the signing of binding agreements with the COVAX Facility coalition and Pfizer.